Median lag between FDA authorization and Medicare coverage hits 6 years: study
Dive Brief: Fewer than 30% of novel medical devices receive nominal or better coverage from Medicare in the three years after regulatory authorization, according to
Dive Brief: Fewer than 30% of novel medical devices receive nominal or better coverage from Medicare in the three years after regulatory authorization, according to
Dive Brief: The U.S. Food and Drug Administration has categorized Getinge’s latest heart assist pump safety notice as a Class I recall. Getinge sent an
Today, we will adventure down a particularly head-spinning rabbit hole that is the intersection between artificial intelligence and psychedelics. These two novel tools have one
Nearly every hospital pharmacy across the U.S. is experiencing shortages of prescription drugs. And the problem has become so bad – especially for chemotherapies —
WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to
atai Reports Q2 2023 Earnings and Provides Ibogaine Phase 1 Update Yesterday, atai Life Sciences reported Q2 2023 financial results along with the first clinical
The last time Kim Kardashian posted about medical imaging, it was to prove her butt was real. Now, she’s praising its ability to find aneurysms